Cargando…
The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy
Osteoarthritis (OA) is one of the most common forms of degenerative joint disease and a major cause of pain and disability affecting the aging population. It is estimated that more than 20 million Americans and 35 to 40 million Europeans suffer from OA. Analgesics and non-steroidal anti-inflammatory...
Autor principal: | Mobasheri, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789888/ https://www.ncbi.nlm.nih.gov/pubmed/24061701 http://dx.doi.org/10.1007/s11926-013-0364-9 |
Ejemplares similares
-
The Future of Osteoarthritis Therapeutics: Emerging Biological Therapy
por: Mobasheri, A.
Publicado: (2013) -
Physicochemical and Biomechanical Stimuli in Cell-Based Articular Cartilage Repair
por: Jahr, Holger, et al.
Publicado: (2015) -
Non-invasive Loading Model of Murine Osteoarthritis
por: Poulet, Blandine
Publicado: (2016) -
Tissue-Engineering Strategies to Repair Chondral and Osteochondral Tissue in Osteoarthritis: Use of Mesenchymal Stem Cells
por: Grässel, Susanne, et al.
Publicado: (2014) -
Anti-oxidation Treatment of Ultra High Molecular Weight Polyethylene Components to Decrease Periprosthetic Osteolysis: Evaluation of Osteolytic and Osteogenic Properties of Wear Debris Particles in a Murine Calvaria Model
por: Green, Justin M., et al.
Publicado: (2013)